1. 037 Efficacy and Tolerability of Dapoxetine and Sertraline for the Treatment of Chinese Patients With Premature Ejaculation. (1st January 2017) Authors: Yang, L.; Chen, X.F.; He, D.L. Journal: Journal of sexual medicine Issue: Volume 14(2017)Supplement 1 Page Start: S17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1303 Preoperative chemoradiation with capecitabine for rectal cancer in elderly patients: A phase I trial. (September 2015) Authors: Liu, W.; Tang, Y.; Jin, J.; Zhang, H.; Yang, L.; Ren, H.; Fang, H.; Wang, W.; Song, Y.; Liu, Y.; Wang, S.; Li, Y. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S188 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1897 RAD001, A mTOR specificity inhibitor, combined with PI3K Inhibitor LY294002, significantly reduced proliferation and induced apoptosis of triple negative breast cancer cell lines MDA-MB-231 through PI3K/Akt/mTOR pathway in vitro. (September 2015) Authors: Sun, G.; Ma, B.; Yang, L.; Dong, C.; Ma, B. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S298 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 2019 年新型冠状病毒的应急处理: 对皮肤科的启示. (1st June 2020) Authors: Tao, J.; Song, Z.; Yang, L.; Huang, C.; Feng, A.; Man, X. Journal: British journal of dermatology Issue: Volume 182:Number 6(2020) Page Start: e207 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 202 Efficacy and Tolerability of Dapoxetine in the Treatment of Chinese Patients With Premature Ejaculation. (1st January 2017) Authors: Yang, L.; Chen, X.F.; He, D.L. Journal: Journal of sexual medicine Issue: Volume 14(2017)Supplement 1 Page Start: S56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 2052 Efficacy and safety of oxaliplatin combined with capecitabine as neoadjuvant chemotherapy for locally advanced operable colon cancer patients: A prospective phase II trial (NCT02415829). (September 2015) Authors: Liu, F.; Yang, L.; Huang, D.; Wang, L.; Xu, J.; Xu, Y. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S346 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 2108 Subgroup analysis by KRAS status in RAISE: A randomized, double-blind phase III study of irinotecan, folinic acid, and 5-fluorouracil (FOLFIRI) plus ramucirumab or placebo in patients with metastatic colorectal carcinoma progression during or following first-line combination therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine. (September 2015) Authors: Van Cutsem, E.; Obermannova, R.; Bodoky, G.; Prausová, J.; García-Carbonero, R.; Ciuleanu, T.; Alfonso, P Garcia; Portnoy, D.; Cohn, A.; Yamazaki, K.; Clingan, P; Yoshino, T.; Polikoff, J.; Lonardi, S.; Macarulla, T.; Yang, L.; Nasroulah, F. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S365 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 2123 Exposure-response (E-R) relationship of Ramucirumab (RAM) from a global, randomized, double-blind, Phase 3 study of patients (Pts) with advanced 2nd line colorectal cancer. (September 2015) Authors: Cohn, A. Lee; Yoshino, T.; Obermannova, R.; Bodoky, G.; Prausova, J.; Garcia-Carbonero, R.; Ciuleanu, T. Eliade; Garcia-Alfonso, P.; Portnoy, D.C.; Van Cutsem, E.; Yamazaki, K.; Clingan, P.R.; Polikoff, J.; Lonardi, S.; Gao, L.; Yang, L.; Chang, S.C.; Ferry, D.; Nasroulah, F.; Tabernero, J. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S372 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 2337 Ramucirumab (RAM) as a second-line treatment in patients with advanced hepatocellular carcinoma (HCC) following first-line therapy with sorafenib in the randomized phase III REACH study: Analysis of alpha-fetoprotein (AFP) kinetics during treatment. (September 2015) Authors: Chau, I.; Park, J.O.; Ryoo, B.Y.; Yen, C.J.; Poon, R.; Pastorelli, D.; Blanc, J.F.; Kudo, M.; Pfiffer, T.F.; Hatano, E.; Chung, H.C.; Kubackova, K.; Phelip, J.M.; Brandi, G.; Ohkawa, S.; Li, C.P.; Okusaka, T.; Yang, L.; Abada, P.; Zhu, A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S446 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 2620 RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Pooled anti-VEGF cohort subanalysis. (September 2015) Authors: Alekseev, B.; Yang, L.; Alyasova, A.; Ye, D.; Karpenko, A.; Li, H.; Xie, L.; Kurteva, G.; Kowalyszyn, R.; Karyakin, O.; Neron, Y.; Cosgriff, T.; Collins, L.; Brechenmacher, T.; Lin, J.; Morgan, L.; Motzer, R. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S518 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗